title: [Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment].
abstract: Adult attention deficit/hyperactivity disorder (ADHD) is characterised by inattention and/or hyperactivity and impulsivity and is a frequent psychiatric disorder with childhood onset. In addition to core symptoms, patients often experience associated symptoms like emotional dysregulation or low self-esteem and suffer from comorbid disorders, particularly depressive episodes, substance abuse, anxiety or sleep disorders. It is recommended to include associated symptoms and comorbid psychiatric disorders in the diagnostic set-up and in the treatment plan. Comorbid psychiatric disorders should be addressed with disorder-specific therapies while associated symptoms also often improve with treatment of the ADHD core symptoms. The most impairing psychiatric disorder should be treated first. This review presents recommendations for differential diagnosis and treatment of adult ADHD with associated symptoms and comorbid psychiatric disorders with respect to internationally published guidelines, clinical trials and expert opinions.
authors.affiliation: Klinik für Psychiatrie und Psychotherapie, Medizinische Fakultät Mannheim, Universität Heidelberg, Zentralinstitut für Seelische Gesundheit, Mannheim.
authors.forename: G
authors.initials: G
authors.lastname: Paslakis
authors.forename: M
authors.initials: M
authors.lastname: Schredl
authors.forename: B
authors.initials: B
authors.lastname: Alm
authors.forename: E
authors.initials: E
authors.lastname: Sobanski
mesh_terms: D000328:Adult / Q000523:psychology*; D001007:Anxiety / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use; D015897:Comorbidity; D006801:Humans; D001523:Mental Disorders / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology*; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D015995:Prevalence; D012893:Sleep Wake Disorders / Q000150:complications / Q000523:psychology / Q000628:therapy; D019966:Substance-Related Disorders / Q000150:complications / Q000523:psychology / Q000628:therapy
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate